M. Xilinas

发表

CONGENITAL DISLOCATION OF THE HIP IN BRITTANY

M. Xilinas, D. Lagarde, Xilinas Me, 1975, The Lancet.

Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting A Amyloid Deposition and Toxicity in Alzheimer Disease

A. Mackinnon, C. Masters, R. Tanzi, 2003 .

Changes in uptake of vitamin B12 and trace metals in brains of mice treated with clioquinol

L. Oreland, C. Gottfries, J. Ekblom, 2000, Journal of the Neurological Sciences.

Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice

C. Masters, Xudong Huang, R. Tanzi, 2001, Neuron.

Treatment of Alzheimer’s Disease with Clioquinol

K. Blennow, M. Jonsson, M. Sjögren, 2001, Dementia and Geriatric Cognitive Disorders.

Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial.

A. Mackinnon, C. Masters, R. Tanzi, 2003, Archives of neurology.

Selective medium for growth of Proteus

N. Legakis, M. Xilinas, J. Papavassiliou, 1975, Journal of clinical microbiology.

Letter: Congenital dislocation of the hip in Brittany.

M. Xilinas, D. Lagarde, 1975, Lancet.

Degradation of the Alzheimer Disease Amyloid β-Peptide by Metal-dependent Up-regulation of Metalloprotease Activity*

C. Masters, A. Hill, A. Bush, 2006, Journal of Biological Chemistry.

Rimactan Parenteral Formulation in Clinical Use

M. Xilinas, M. Kissling, 1981, The Journal of international medical research.